Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001644956-25-000027·AMICUS THERAPEUTICS, INC.
Schedule 13G ownership disclosure
Amicus Therapeutics Inc
Common Stock · CUSIP: 03152W109
Event date: 2025-03-31
- Filing-level shares
- 14,778,651.00
- Percent of class
- 4.9%
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
Shares: 14,778,651.00 · Class: 4.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001644956-25-000027
- Form type
- SCHEDULE 13G/A
- Filer
- AMICUS THERAPEUTICS, INC.
- CIK
- CIK 1178879
- Filed
- May 09, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership